Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Norwegian Biotech AS
AS
Active
Org 834824582
Kannikgata 27, 4008
Stavanger
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
— employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Norwegian Biotech AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
Revenue
0
Staff expenses
−0
EBITDA
−31
Depreciation & amort.
−0
EBIT
−31
Net financials
0
Profit before tax
−31
Tax
−7
Net profit
−24
Balance sheet
NOK thousands
Item
2025
Total assets
20
Equity
0
Long-term debt
0
Short-term debt
20
Total debt
20
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2025
2025
Equity ratio
1,9 %
This company
38,2 %
Market median
This company
Market median
95% below market
2025
2025
Return on equity
<−999 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2025
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2025
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2025
2025
Debt / equity
52,57×
This company
0,62×
Market median
This company
Market median
>999% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-10-20 – 2025-12-31
View
PDF
More on Norwegian Biotech AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
